Jiedong Qiu
Papers
1
Total Citations
8
H-Index
1
About
Dr. Jiedong Qiu is a biomedical researcher whose work focuses on the intersection of metabolic disease and renal pathology, with a particular emphasis on diabetic kidney disease (DKD). Dr. Qiu’s most significant contributions center on the role of carnosinase 1 (CN1) in type 2 diabetes (T2D) complications. In a landmark 2022 study, Dr. Qiu established the first comprehensive assessment of serum CN1 concentration and activity as potential biomarkers for renal function impairment in T2D patients. This work, which has garnered 8 citations, bridges a critical gap between genetic associations and clinical diagnostics, demonstrating that CN1 levels may serve as early indicators of DKD progression. By moving beyond genetic polymorphisms to functional enzyme analysis, Dr. Qiu has opened new avenues for non-invasive disease monitoring. The study’s rigorous methodology—including cohort-based validation—highlights Dr. Qiu’s commitment to translational research that directly impacts patient care. This foundational contribution positions Dr. Qiu as a rising authority in diabetic nephropathy biomarker discovery, with implications for both early detection and therapeutic targeting of carnosinase pathways.
Research Focus
Key Achievements
Top Papers
- 1